Oxford Asset Management’s Amicus Therapeutics FOLD Stock Holding History

Oxford Asset Management’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$720K	Sell	49,811 -118,703	-70%	-$1.7M	0.31%	85
2025 Q4	$2.4M	Buy	168,514 +141,899	+533%	+$1.39M	0.88%	6
2025 Q3	$210K	Sell	26,615 -13,905	-34%	-$99K	0.07%	376
2025 Q2	$232K	Buy	+40,520	New	+$262K	0.08%	394
2024 Q3	–	Sell	-19,099	Closed	-$189K	–	356
2024 Q2	$189K	Buy	+19,099	New	+$196K	0.18%	214
2020 Q1	–	Sell	-147,903	Closed	-$1.44M	–	613
2019 Q4	$1.44M	Buy	+147,903	New	+$1.35M	0.04%	623
2019 Q2	–	Sell	-36,473	Closed	-$496K	–	1795
2019 Q1	$496K	Buy	+36,473	New	+$446K	0.01%	1222
2018 Q2	–	Sell	-83,777	Closed	-$1.26M	–	1773
2018 Q1	$1.26M	Buy	+83,777	New	+$1.27M	0.03%	822
2016 Q1	–	Sell	-614,976	Closed	-$5.96M	–	834
2015 Q4	$5.96M	Buy	+614,976	New	+$5.54M	0.14%	149
2015 Q2	–	Sell	-458,701	Closed	-$4.99M	–	683
2015 Q1	$4.99M	Buy	458,701 +181,816	+66%	+$1.6M	0.13%	182
2014 Q4	$2.28M	Buy	276,885 +263,616	+1,987%	+$1.81M	0.05%	355
2014 Q3	$79K	Buy	+13,269	New	+$69.5K	﹤0.01%	651
2014 Q2	–	Sell	-104,166	Closed	-$216K	–	722
2014 Q1	$216K	Buy	+104,166	New	+$260K	0.01%	590

Other funds holding FOLD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Oxford Asset Management's FOLD Position: Q1 2026 in Review

Oxford Asset Management reduced its Amicus Therapeutics (FOLD) stake by 70% in Q1 2026, selling an estimated $1.7M and leaving 49,811 shares worth $720K. The position accounts for 0.31% of the portfolio, ranked #85.

Oxford Asset Management first reported a position in FOLD in Q1 2014 and has held it in 13 quarters since. The position peaked at $5.96M in Q4 2015. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

Oxford Asset Management held 49,811 shares of Amicus Therapeutics worth $720K as of Q1 2026.
Oxford Asset Management sold 118,703 Amicus Therapeutics shares in Q1 2026, an estimated $1.7M.
Amicus Therapeutics made up 0.31% of Oxford Asset Management's portfolio in Q1 2026, its #85 holding.
Oxford Asset Management first reported a position in Amicus Therapeutics in Q1 2014 and has held it in 13 quarters since.
Oxford Asset Management's Amicus Therapeutics position peaked at $5.96M in Q4 2015.
298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Oxford Asset Management's 13F filing for Q1 2026, filed 15 May 2026.